Puma Biotechnology, Inc. (PBYI)
7.13
-0.09
(-1.25%)
USD |
NASDAQ |
Nov 19, 16:00
7.13
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price : 7.13 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 7.15 | 7.36 | 7.01 | 7.22 | 454066.0 |
| Nov 17, 2026 | 7.28 | 7.37 | 6.92 | 7.14 | 593814.0 |
| Nov 16, 2026 | 7.73 | 7.816 | 7.265 | 7.34 | 548862.0 |
| Nov 13, 2026 | 8.08 | 8.12 | 7.75 | 7.77 | 403674.0 |
| Nov 12, 2026 | 8.08 | 8.246 | 8.075 | 8.08 | 448734.0 |
| Nov 11, 2026 | 8.21 | 8.311 | 8.02 | 8.08 | 397809.0 |
| Nov 10, 2026 | 8.35 | 8.56 | 8.06 | 8.14 | 602373.0 |
| Nov 09, 2026 | 8.28 | 8.56 | 8.10 | 8.395 | 750644.0 |
| Nov 06, 2026 | 8.27 | 8.65 | 7.594 | 8.25 | 1.280M |
| Nov 05, 2026 | 10.75 | 10.88 | 9.77 | 9.77 | 490930.0 |
| Nov 04, 2026 | 10.47 | 10.85 | 10.32 | 10.69 | 475209.0 |
| Nov 03, 2026 | 10.23 | 10.42 | 10.08 | 10.22 | 406502.0 |
| Nov 02, 2026 | 10.46 | 10.52 | 10.11 | 10.18 | 399286.0 |
| Oct 30, 2026 | 10.56 | 10.66 | 10.36 | 10.44 | 339537.0 |
| Oct 29, 2026 | 10.75 | 10.81 | 10.51 | 10.54 | 224287.0 |
| Oct 28, 2026 | 10.83 | 10.95 | 10.53 | 10.62 | 419546.0 |
| Oct 27, 2026 | 10.86 | 11.06 | 10.76 | 10.92 | 308905.0 |
| Oct 26, 2026 | 11.11 | 11.32 | 10.73 | 10.85 | 355705.0 |
| Oct 23, 2026 | 11.25 | 11.50 | 10.91 | 11.02 | 559164.0 |
| Oct 22, 2026 | 10.93 | 11.38 | 10.92 | 11.26 | 395525.0 |
| Oct 21, 2026 | 10.73 | 10.98 | 10.61 | 10.90 | 306291.0 |
| Oct 20, 2026 | 10.23 | 10.84 | 10.21 | 10.76 | 364916.0 |
| Oct 19, 2026 | 9.85 | 10.28 | 9.74 | 10.21 | 459899.0 |
| Oct 16, 2026 | 10.51 | 10.51 | 9.81 | 9.83 | 406597.0 |
| Oct 15, 2026 | 10.30 | 10.72 | 10.28 | 10.52 | 377439.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Olema Oncology, Inc. | 7.175 |
| Anika Therapeutics, Inc. | 13.29 |
| ACADIA Pharmaceuticals, Inc. | 17.59 |
| Alnylam Pharmaceuticals, Inc. | 147.82 |
| Savara, Inc. | 5.205 |
Price Related Metrics
| PE Ratio | 15.68 |
| PS Ratio | 1.600 |
| Price to Book Value | 2.514 |
| Price to Free Cash Flow | 8.050 |
| Earnings Yield | 6.38% |
| Market Cap | 368.54M |
| Operating PE Ratio | 14.19 |
| Normalized PE Ratio | 15.68 |